Last reviewed · How we verify

NCT04286009

Pathogenesis and Mechanisms of Mitral Annular Calcification

Completed Last updated 23 July 2024
What this trial tests

trial in Mitral Annulus Calcification in 45 participants. Completed in 1 April 2024.

Timeline
28 July 2020
Primary endpoint
1 April 2024
1 April 2024

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment45
Start date28 July 2020
Primary completion1 April 2024
Estimated completion1 April 2024
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 90, any sex, with Mitral Annulus Calcification. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mitral Annulus Calcification

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04286009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing